We thank the following for their support:
Ortho-McNeil is the distributor of Elmiron®, the first and only oral medication FDA-approved specifically for the treatment of IC.
http://www.elmiron100.com/
Medtronic Foundation is the philanthropic organization of Medtronic, Inc. The Medtronic Foundation supports a variety of Programs and Services for non-profit organizations aimed at empowering people with chronic disease.
www.medtronic.com/foundation
Astellas USA Foundation is the US philanthropic division of Astellas Pharma, Inc. of Japan. Launched in April 2005, Astellas was formed by the historical merger of Japan's third and fifth largest pharmaceutical companies - Yamanouchi, founded in 1923, and Fujisawa, founded in 1894. With an unrelenting commitment to R&D as a value-creating core of its business, Astellas is consolidated around complementary strengths from Yamanouchi and Fujisawa.
http://www.astellas.com/
Medtronic, Inc. is the maker of InterStim (R) Therapy, an implantable sacral nerve stimulation device for the treatment of urgency frequency, urge incontinence and retention.
http://www.medtronic.com/ or http://www.interstim.com/
Alaven Pharmaceutical LLC, the maker of CystoProtek® a patent-protected natural oral dietary supplement in softgel capsule form. CystoProtek has been clinically demonstrated to relieve symptoms associated with interstitial cystitis. For more information please visit http://www.cysto-protek.com or call 888-317-0001.
Uroplasty is a global medical device company that develops, manufactures and markets products for the minimally invasive treatment of voiding dysfunctions and pelvic disorders including urinary incontinence and overactive bladder symptoms.
http://www.uroplasty.com
Desert Harvest provides special over-the-counter aloe vera formulas that are specifically designed to target the symptoms of IC.
http://www.desertharvest.com/ [Free Samples Available]
Astra Tech, Inc., the maker of the LoFric® hydrophilic catheters and kits for intermittent catheterization. LoFric is the only catheter in the world proven to reduce the risk of both UTIs and long-term complications. 100% latex-free. For more information please visit http://www.lofric.com/.
We are making great strides thanks in part to the generous support from our Sponsors. The efforts of these companies have helped to make positive changes in the lives of IC patients. Our sponsors have contributed to many of the vital programs offered by the ICA --- programs that continue to reach out to patients, their families, and health care professionals --- helping to make a difference.
As a nonprofit organization (a "dot-org" with a 501(c)(3) charitable designation), the ICA relies on corporate support to cover the costs associated with the creation, production, and disbursement of our publications, resource materials, educational packets, and Web site pages. These partnerships allow us to continue our more than twenty-year history of delivering quality education, support, and advocacy services to thousands of interstitial cystitis patients, caregivers, physicians, and researchers worldwide.
Every corporate donation furthers the search for better treatment options and, ultimately, a cure for interstitial cystitis. Corporate leaders recognize ICA sponsorship as an effective communications tool bringing value to their companies and special acknowledgment and appreciation from the ICA's community. Because the ICA is a nonprofit service organization, these corporate contributions are tax-deductible to the fullest extent allowed by law.
More information about these sponsors and their products can be found by clicking on the links above. Please recognize that these are commercial sites and, as such, may contain promotional material not necessarily endorsed by the ICA.